It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Writer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
First known COVID-19 case was vendor at Wuhan market, scientist claims

Asia Pacific Nov 19, 2021

First known COVID-19 case was vendor at Wuhan market, scientist claims

The report will revive the debate over whether the pandemic started with a spillover from wildlife sold at the market, a leak from a Wuhan virology lab or some other way.

Studies show vaccines are effective against delta variant

World / Science & Health Jul 7, 2021

Studies show vaccines are effective against delta variant

Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

World Apr 13, 2021

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.

Study shows COVID-19 variant spreading in Britain could become resistant to vaccines

World Feb 2, 2021

Study shows COVID-19 variant spreading in Britain could become resistant to vaccines

Experiments in test tubes suggest that some of its mutations allow the coronavirus to hold onto cells more tightly.

Two companies say their vaccines are 95% effective. What does that mean?

World / Science & Health Nov 21, 2020

Two companies say their vaccines are 95% effective. What does that mean?

You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that’s not how the math works.

Moderna’s COVID-19 vaccine: What you need to know

World / Science & Health Nov 17, 2020

Moderna’s COVID-19 vaccine: What you need to know

Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there’s going to be a way out of the pandemic.

Johnson & Johnson’s vaccine advances, sparking optimism in race

World / Science & Health Sep 24, 2020

Johnson & Johnson’s vaccine advances, sparking optimism in race

The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.

« 1 2
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

SUSTAINABLE JAPAN

Support our journalism

Staying informed during times of uncertainty is crucial, which is why The Japan Times is providing free access to select stories about the coronavirus pandemic. Please consider subscribing today and support our efforts to deliver the news that matters.
SUBSCRIBE NOW
The Japan Times circular logo

SPECIAL SUPPLEMENTS

Sponsored contents planned and edited by JT Media Enterprise Division.

広告出稿に関するおといあわせはこちらまで

Read more

SUPPLEMENTS BINDER

international-reports
  • Bridges by SMS
  • Global Insight
  • GMI Post
  • World Eye Reports
Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times